biology

Mitochondrial membrane protein-associated neurodegeneration

Mitochondrial membrane protein-associated neurodegeneration is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mitochondrial membrane protein-associated neurodegeneration rather than just read about it. In short: Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a genetic neurodegenerative disease that causes dystonia, parkinsonism, and iron accumulation in the brain. It is caused by mutations to the gene C19orf12, which has unknown function.

Key takeaways

Mitochondrial membrane protein-associated neurodegeneration belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Mitochondrial membrane protein-associated neurodegeneration to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Mitochondrial membrane protein-associated neurodegeneration from memory before moving on to harder problems.

Reference excerpt

Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a genetic neurodegenerative disease that causes dystonia, parkinsonism, and iron accumulation in the brain. It is caused by mutations to the gene C19orf12, which has unknown function. This was originally discovered as an autosomal recessive disorder, caused by individuals having two mutations to the gene C19orf12, but autosomal dominant disease caused by a single mutation in the same gene has also been rarely described. Due to the common features of neurodegeneration, brain iron accumulation, and movement disorder it is classified as a neurodegeneration with brain iron accumulation (NBIA) disorder and another name for the condition is neurodegeneration with brain iron accumulation 4 (NBIA4).

Signs and symptoms Symptoms typically begin in childhood and worsen over time. Typical initial features include difficulty walking and dystonia, with later progression to difficulty moving called parkinsonism. Associated problems can include optic nerve atrophy. As movement difficulties worsen, it can cause difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and dementia.

Genetics MPAN is caused by variants to a single gene, C19orf12, the function of which is not currently known. The more common form is caused by an individual having two dysfunctional copies of C19orf12 which are typically inherited from unaffected parents carrying one mutated copy and one normal copy (carrier status). This is called autosomal recessive inheritance. More rarely described are individuals with a single dysfunctional copy of C19orf12 causing disease, considered to be an autosomal dominant form of the disease that can either be inherited or arise from a de novo mutation. The protein C19orf12 is not well understood, it is expressed in most cells and is thought to localize to mitochondria and the endoplasmic reticulum.

Diagnosis MPAN might be suspected with typical presentation and findings on MRI (Magnetic Resonance Imaging), these include evidence of iron deposition in the brain, particularly in the basal ganglia (globus pallidus and substantia nigra). The diagnosis is confirmed by genetic testing identifying harmful variant(s) in C19orf12.

Neuropathology Pathological findings in brains of people with MPAN include iron deposition and scarring in the globus pallidus, loss of neurons in the substantia nigra, and widespread Lewy bodies and spherical bodies from degenerating neurons.

Management There are no current treatments or clinical trials for MPAN, so medical treatment focusses on relief of symptoms such as spasticity and dystonia using medications (such as gabapentin, trihexyphenidyl or baclofen), or surgery.

Prognosis MPAN typically progresses more slowly than other NBIA disorders, and people usually survive into adulthood. As it progresses, people have more difficulty with cognition, speaking, swallowing, movement difficulties, and neuropsychiatric problems.

Epidemiology Prevalence data regarding this disorder remains incomplete, however it is estimated that less than 1 in 1,000,000 have the disease worldwide. It is more common in Turkish people, due to a founder mutation.

History MPAN was first described in 2011 in 24 Polish patients with mutations in C19orf12, later confirmed in a further 23 people.

References

External links

Worked examples

Example 1 — a first encounter with Mitochondrial membrane protein-associated neurodegeneration

Start with the simplest possible case. Write down what Mitochondrial membrane protein-associated neurodegeneration claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mitochondrial membrane protein-associated neurodegeneration before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mitochondrial membrane protein-associated neurodegeneration ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mitochondrial membrane protein-associated neurodegeneration

In research: Mitochondrial membrane protein-associated neurodegeneration appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Mitochondrial membrane protein-associated neurodegeneration in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Mitochondrial membrane protein-associated neurodegeneration is common in secondary-school and first-year university syllabi. It links to neighbouring topics Extrapyramidal and movement disorders, Neurodegeneration with brain iron accumulation, Syndromes affecting the nervous system, so understanding it makes those chapters shorter.
In everyday life: Look for Mitochondrial membrane protein-associated neurodegeneration outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mitochondrial membrane protein-associated neurodegeneration” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mitochondrial membrane protein-associated neurodegeneration in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Mitochondrial membrane protein-associated neurodegeneration means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Mitochondrial membrane protein-associated neurodegeneration out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mitochondrial membrane protein-associated neurodegeneration in simple terms?

Why does Mitochondrial membrane protein-associated neurodegeneration matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mitochondrial membrane protein-associated neurodegeneration?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mitochondrial membrane protein-associated neurodegeneration.